Supernus Pharmaceuticals Inc. (SUPN) Financial Statements (2026 and earlier)

Company Profile

Business Address 9715 KEY WEST AVENUE
ROCKVILLE, MD 20850
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

12/31/2025
12/31/2024
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments69,331461,334339,680422,533347,073356,018
Cash and cash equivalent69,33193,120203,434288,640181,381192,248
Short-term investments  368,214136,246133,893165,692163,770
Receivables142,077165,497148,932140,87787,332102,922
Inventory, net of allowances, customer advances and progress billings54,29391,54185,95948,32526,62825,659
Inventory54,29391,54185,95948,32526,62825,659
Other undisclosed current assets420,36915,77927,01918,68211,6118,888
Total current assets:686,070734,151601,590630,417472,644493,487
Noncurrent Assets
Operating lease, right-of-use asset     21,279✕
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization11,545  37,82417,0684,095
Long-term investments and receivables  93,896119,166350,359591,773418,798
Long-term investments  93,896119,166350,359591,773418,798
Intangible asset, including goodwill, after accumulated amortization638,931819,482902,209442,25324,84031,368
Goodwill117,019117,019117,51677,911  
Intangible asset, excluding goodwill, after accumulated amortization521,912702,463784,693364,34224,84031,368
Restricted cash and investments      
Deferred income tax assets    32,063✕
Other noncurrent assets31,52739,80649,23243,249615380
Deferred tax assets, net✕✕✕✕✕✕29,683
Other undisclosed noncurrent assets  15,17316,955   
Total noncurrent assets:682,003968,3571,087,562873,685687,638484,324
TOTAL ASSETS:1,368,0731,702,5081,689,1521,504,1021,160,282977,811
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities76,35296,342117,68378,93449,71452,107
Taxes payable✕✕✕  2,44312,377
Accounts payable     10,1413,195
Accrued liabilities76,35296,342117,68378,93437,13036,535
Debt  401,968 3,7612,825 
Business combination, contingent consideration, liability47,34021,12044,84030,900  
Other liabilities 16,86320,1329,082  
Other undisclosed current liabilities168,705151,665132,724122,431108,048109,246
Total current liabilities:292,397687,958315,379245,108160,587161,353
Noncurrent Liabilities
Long-term debt and lease obligation   420,550390,330375,610329,462
Long-term debt, excluding current maturities   379,252361,751345,170329,462
Liabilities, other than long-term debt39,943128,346137,372123,8069,40911,398
Deferred income tax liabilities 4,96149,80985,35535,215 ✕
Other liabilities7,6008,69216,38042,7919,40911,398
Operating lease, liability27,38235,99841,29828,57930,440✕
Business combination, contingent consideration, liability 33,84735,63745,800  
Other undisclosed noncurrent liabilities     19,24822,575
Total noncurrent liabilities:39,943128,346557,922514,136404,267363,435
Total liabilities:332,340816,304873,301759,244564,854524,788
Equity
Equity, attributable to parent1,035,733886,204815,851744,858595,428453,023
Common stock565453535352
Additional paid in capital479,440408,115434,337409,332388,410369,637
Accumulated other comprehensive income (loss)(189)(3,210)1,5398,9757,417(3,158)
Retained earnings556,426481,245379,922326,498199,54886,492
Total equity:1,035,733886,204815,851744,858595,428453,023
TOTAL LIABILITIES AND EQUITY:1,368,0731,702,5081,689,1521,504,1021,160,282977,811

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

12/31/2025
12/31/2024
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues661,817667,238579,775520,397392,755408,897
Cost of revenue(161,573)(166,341)(95,920)(65,761)(16,660)(15,356)
Cost of product and service sold(77,906)(87,221)(75,061)(52,459)(16,660)(15,356)
Gross profit:500,244500,897483,855454,636376,095393,541
Operating expenses(418,578)(454,773)(397,826)(280,938)(227,524)(249,097)
Operating income (loss):81,66646,12486,029173,698148,571144,444
Nonoperating income (expense)16,20414,619(12,854)(5,050)(1,084)(4,268)
Investment income, nonoperating      13,843
Other nonoperating income (expense)16,20414,619(12,854)(5,050)(1,084) 
Interest and debt expense  (2,416)(19,696)(19,435)(18,207)(13,840)
Income (loss) from continuing operations before equity method investments, income taxes:97,87058,32753,479149,213129,280126,336
Other undisclosed income from continuing operations before income taxes  2,41619,69619,43518,20713,840
Income (loss) from continuing operations before income taxes:97,87060,74373,175168,648147,487140,176
Income tax expense (benefit)(24,005)(32)(19,751)(41,698)(34,431)(29,183)
Income (loss) from continuing operations:73,86560,71153,424126,950113,056110,993
Income before gain (loss) on sale of properties:✕✕✕53,424126,950113,056110,993
Net income (loss) attributable to parent:73,86560,71153,424126,950113,056110,993
Other undisclosed net income available to common stockholders, basic  3,556    
Net income (loss) available to common stockholders, basic:73,86564,26753,424126,950113,056110,993
Interest on convertible debt  3,556    
Net income (loss) available to common stockholders, diluted:73,86567,82353,424126,950113,056110,993

Comprehensive Income ($ in thousands)
Annual | Quarterly

12/31/2025
12/31/2024
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income (loss):73,86560,71153,424126,950113,056110,993
Comprehensive income (loss):73,86560,71153,424126,950113,056110,993
Other undisclosed comprehensive income (loss), net of tax, attributable to parent404(4,749)(7,436)1,55810,575(2,411)
Comprehensive income (loss), net of tax, attributable to parent:74,26955,96245,988128,508123,631108,582

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: